TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
35 hedge funds and large institutions have $5.47M invested in Titan Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less capital invested
Capital invested by funds: $10.9M → $5.47M (-$5.41M)
Holders
35
Holding in Top 10
–
Calls
$190K
Puts
–
Top Buyers
| 1 | +$576K | |
| 2 | +$437K | |
| 3 | +$289K | |
| 4 |
ECM
Element Capital Management
New York
|
+$156K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$136K |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$354K | |
| 3 | -$311K | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$180K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$128K |